| Mathematical model of tumor–immune surveillance KJ Mahasa, R Ouifki, A Eladdadi, L de Pillis Journal of theoretical biology 404, 312-330, 2016 | 89 | 2016 |
| Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach KJ Mahasa, A Eladdadi, L De Pillis, R Ouifki Plos one 12 (9), e0184347, 2017 | 61 | 2017 |
| Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy KJ Mahasa, L De Pillis, R Ouifki, A Eladdadi, P Maini, AR Yoon, CO Yun Scientific reports 10 (1), 425, 2020 | 47 | 2020 |
| Natural killer cells recruitment in oncolytic virotherapy: a mathematical model NS Senekal, KJ Mahasa, A Eladdadi, L de Pillis, R Ouifki Bulletin of Mathematical Biology 83 (7), 75, 2021 | 12 | 2021 |
| A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept KJ Mahasa, R Ouifki, A Eladdadi, L de Pillis Mathematical Biosciences and Engineering 19 (5), 4429-4457, 2022 | 10 | 2022 |
| Mathematical Modeling for Systemically Administered Oncolytic Adenovirus Loaded with Mesenchymal Stem Cells IW Kim, KJ Mahasa, L de Pillis, R Ouifki, A Eladdadi, P Maini, A Yoon, ... MOLECULAR THERAPY 28 (4), 155-155, 2020 | | 2020 |
| Mathematical Modelling of Tumour-Immune Interactions and Cancer Therapy KJ Mahasa Stellenbosch: Stellenbosch University, 2017 | | 2017 |
| Mathematical modelling of drug resistance in malignant tumour treatment. KJ Mahasa | | 2014 |
Lisette de PillisHarvey Mudd College在 hmc.edu 的电子邮件经过验证
